Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2005
09/22/2005US20050209133 Glycoprotein synthesis
09/22/2005US20050209121 Proteins with changed epitopes and methods for the production thereof
09/22/2005US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor
09/22/2005US20050208627 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells
09/22/2005US20050208625 Monoclonal antibodies with reduced immunogenicity
09/22/2005US20050208619 29 human secreted proteins
09/22/2005US20050208617 Human-like glycoproteins; for hydrolysis of oligosaccharide substrates for N-glycan processing in secretory pathway
09/22/2005US20050208589 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
09/22/2005US20050208580 Novel protein and method for producing the protein
09/22/2005US20050208565 29 human cancer associated proteins
09/22/2005US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant
09/22/2005US20050208552 Corpuscles of Stannius protein, stanniocalcin
09/22/2005US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
09/22/2005US20050208536 Comprises ribonuclease barnase marker gene; libraries; drug resistance
09/22/2005US20050208530 Using recombination reaction, primer extension and dideoxynucleotides to sequence all or part of a nucleic acid segment
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208521 Modulation signal transduction; isolated nucleic acids; genetic engineering
09/22/2005US20050208508 Gene encoding labyrinthin, a marker for cancer
09/22/2005US20050208494 Novel proteins and dnas thereof
09/22/2005US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection
09/22/2005US20050208479 Immunoglobulin for prevention of variola infection; immunotherapeutics
09/22/2005US20050208474 Method and cell composition for screening compounds for anti-inflammatory activity
09/22/2005US20050208178 Microbially expressed xylanases and their use as feed additives and other uses
09/22/2005US20050208140 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid
09/22/2005US20050208121 Polymeric cannulae proteins, nucleic acids encoding them and methods for making and using them
09/22/2005US20050208066 Fusion proteins; severe acute respiratory syndrome coronavirus; double-stranded RNA; drug screening
09/22/2005US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening
09/22/2005US20050208053 Administering very late antigen-4, antigen binding fragment thereof, soluble vascular cell adhesion molecule-1 polypeptide; chimera
09/22/2005US20050208046 TWEAK receptor
09/22/2005US20050208044 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/22/2005US20050208040 Polynucleotides and polypeptides encoded thereby
09/22/2005US20050208038 Isolated polypeptide is amino acid sequence; lytic enzyme comprises a first isolated amino acid sequence homolog; In vitro Killing Assay; In vivo Nasal Infection Assay
09/22/2005US20050208011 Hair follicle growth
09/22/2005US20050205833 Recombinant peptide
09/22/2005US20050205489 Positioned upstream of system inlet, reduces presence of non specific binding species; hydrophobic, lipophilic, activated carbon, cations, anions, ligands; fumed silica, glass; fibers, beads, membranes; affinity chromatography columns, ultrafiltration systems
09/22/2005CA2564614A1 Combinatorial interleukin-2 muteins
09/22/2005CA2559172A1 Therapeutic use of rm1 antigen
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2558911A1 Process for producing polypeptides
09/22/2005CA2558811A1 Dimeric fusion proteins and materials and methods for producing them
09/22/2005CA2558632A1 Improved interleukin-2 muteins
09/22/2005CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577383A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof
09/21/2005EP1577382A2 Detection of TSE infectivity
09/21/2005EP1577319A1 Prefilter system for biological systems
09/21/2005EP1576182A2 Product quality enhancement in mammalian cell culture processes for protein production
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576151A2 Ap1 amine oxidase variants
09/21/2005EP1576140A2 Synthetic genes
09/21/2005EP1576137A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1576136A2 Methods for identifying antimicrobial compounds
09/21/2005EP1576117A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
09/21/2005EP1576116A2 Methods and materials relating to novel polypeptides and polynucleotides
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576106A2 Process and materials for production of glucosamine and n-acetylglucosamine
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576100A2 Purified composition of bispecific molecules and methods of production
09/21/2005EP1576097A2 Multimeric ligands with enhanced stability
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1575999A2 Increasing production of proteins in gram-positive microorganisms
09/21/2005EP1575998A2 Mammalian cell culture processes for protein production
09/21/2005EP1575996A2 Genes involved in neuropsychiatric disorders
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
09/21/2005EP1575988A2 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575917A2 Hemipteran muscarinic receptor
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1499739A4 Methods for increasing homologous recombination of a nucleic acid sequence
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP0994954B1 T7 promoter-based expression system
09/21/2005EP0974057B1 Methods to detect hk2 polypeptides
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN1671848A Method for enhancing yield of recombinant protein production from plants
09/21/2005CN1671840A Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them
09/21/2005CN1671837A Neutralizing human anti-IGFR antibody
09/21/2005CN1671741A Buffered formulations for concentrating antibodies and methods of use thereof
09/21/2005CN1671737A Export and modification of (poly)peptides in the lantibiotic way
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1671416A Super humanized antibodies
09/21/2005CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method
09/21/2005CN1219889C Cyclosporins A fermentation production method
09/21/2005CN1219888C Methods of synthesizing cell-free protein
09/21/2005CN1219881C Human protooncogene and protein encoded therein
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 1125